Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-13 | 2024-03 | -0.11 | N/A | N/A | N/A |
2024-02-29 | 2023-12 | -0.23 | -0.02 | 0.21 | 91.30% |
2023-11-14 | 2023-09 | -0.27 | -0.25 | 0.02 | 7.41% |
2023-08-07 | 2023-06 | -0.34 | -0.29 | 0.05 | 14.71% |
2023-05-11 | 2023-03 | -0.32 | -0.31 | 0.01 | 3.13% |
2023-03-15 | 2022-12 | 0 | -0.31 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-03 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-03-15 | HC Wainwright & Co. | Upgrade | Buy | |
2022-10-25 | Ladenburg Thalmann | Upgrade | Buy | |
2022-01-30 | HC Wainwright & Co. | Upgrade | Buy | |
2021-10-10 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-05 | AUWAERTER PAUL GISBERT | Director | 5.00K | Purchase |
2023-04-16 | AVAT XAVIER | Former | 0.00 | Sale |
2023-10-22 | BERGMANN ANTHONY | Chief Financial Officer | 2.38K | Conversion of Exercise of derivative security |
2024-04-22 | COLLIER EARL M JR | Director | 56.86K | Conversion of Exercise of derivative security |
2023-02-13 | DUNBAR GEORGE W JR | Director | 10.56K | Conversion of Exercise of derivative security |
2022-11-02 | KRASNEY KAREN | General Counsel | 20.05K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.15M | 5.48M | 4.45% |
2023-06-29 | Blackrock Inc. | 410.92K | 1.96M | 1.59% |
2023-06-29 | Geode Capital Management, LLC | 298.32K | 1.43M | 1.16% |
2023-06-29 | Northern Trust Corporation | 105.51K | 504.32K | 0.41% |
2023-06-29 | Bank Of New York Mellon Corporation | 84.54K | 404.12K | 0.33% |
2023-06-29 | State Street Corporation | 84.92K | 405.94K | 0.33% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 767.24K | 3.67M | 2.98% |
2023-06-29 | Vanguard Extended Market Index Fund | 335.76K | 1.60M | 1.30% |
2023-05-30 | Fidelity Extended Market Index Fund | 114.14K | 517.07K | 0.44% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 50.16K | 325.05K | 0.19% |
2023-08-30 | iShares Micro Cap ETF | 49.37K | 319.93K | 0.19% |
2023-05-30 | Fidelity Total Market Index Fund | 43.59K | 197.45K | 0.17% |
Split | Date |
---|---|
1 : 10 | 2019-06-05 |
0.02 : 1 | 2013-11-21 |
-
I meant $4.83 but $7.83 would be really nice haha
-
$CAPR I see a bid for over 71k shares for $7.83
-
-
-
men of little faith
-
$CAPR need some good news during ER so I can get out of the Flaming red CAPR! Gotta love my average buy in of $8.62
-
-
-
Don't Sell
-
-
-
-
-
$OBSV Analysts expect $16-$36 per share.
Shareholders will be ecstatic, with their stake up 30% over the past week following ObsEva SA‘s (NASDAQ:OBSV) latest quarterly results. Revenues came in 113% better than analyst models expected, at US$4.0kwhile statutory losses per share were US$0.48, in line with forecasts. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
-
-
-
-
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
globenewswire.com • -
Capricor Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com • -
Capricor Therapeutics, Inc. (CAPR) Q3 2023 Earnings Call Transcript
seekingalpha.com • -
Capricor Therapeutics, Inc. (CAPR) Q2 2023 Earnings Call Transcript
seekingalpha.com • -
Capricor Therapeutics, Inc. (CAPR) Q1 2023 Earnings Call Transcript
seekingalpha.com • -
Capricor Therapeutics, Inc. (CAPR) Q3 2022 Earnings Call Transcript
seekingalpha.com • -
Capricor Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com • -
7 Undervalued Penny Stocks With Major Upside
investorplace.com • -
CAPR Stock: Why It Substantially Increased Today
pulse2.com • -
Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts
pennystocks.com • -
Capricor Therapeutics to Participate in BIO Digital 2021 Conference
globenewswire.com • -
Capricor Therapeutics (CAPR) Investor Presentation - Slideshow
seekingalpha.com • -
Capricor Therapeutics (NASDAQ:CAPR) Coverage Initiated by Analysts at Maxim Group
thelincolnianonline.com • -
ThermoGenesis Holdings: Many Short-Term Catalysts In Low-Float Stock
seekingalpha.com • -
Capricor to Participate in BIO Digital International Convention
finance.yahoo.com • -
Here is What Hedge Funds Think About Capricor Therapeutics, Inc. (CAPR)
finance.yahoo.com • -
Moderna y Sorrento se disparan en Bolsa por sus avances en el desarrollo de una cura
cincodias.elpais.com • -
Capricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com • -
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
investing.com • -
5 Stem Cell Companies Racing Towards COVID-19 ARDS Therapy
seekingalpha.com • -
Capricor (CAPR) Shares Could Hit $10, Says Analyst
finance.yahoo.com • -
Cómo hacerse millonario con una presunta cura en una sola sesión de Wall Street
cincodias.elpais.com • -
RDS.A, LYG among premarket losers
seekingalpha.com • -
108 Biggest Movers From Yesterday
benzinga.com • -
Capricor Therapeutics Shares Soar 250% On Successful COVID-19 Treatment News
finance.yahoo.com • -
82 Stocks Moving In Wednesday's Mid-Day Session
benzinga.com •